Close Menu

NEW YORK (GenomeWeb) – Illumina will build a new 150,000-square-foot facility in San Diego to house manufacturing and logistics, the company and the city said on Tuesday.

When completed, the new space will add about 300 new "high-wage" jobs to the current 1,500 workers already employed by the firm, a spokesman for Illumina said. The new facility will be located at the company's headquarters campus, he added.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.